Comment on 'Immune response to COVID-19 mRNA vaccination in patients with psoriasis undergoing treatment with biologics'

dc.authoridAltunisik, Nihal/0000-0001-6844-1097
dc.contributor.authorToplu, Sibel Altunisik
dc.contributor.authorAltunisik, Nihal
dc.date.accessioned2024-08-04T20:55:11Z
dc.date.available2024-08-04T20:55:11Z
dc.date.issued2024
dc.departmentİnönü Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1093/ced/llad392
dc.identifier.endpage394en_US
dc.identifier.issn0307-6938
dc.identifier.issn1365-2230
dc.identifier.issue4en_US
dc.identifier.pmid37966357en_US
dc.identifier.scopus2-s2.0-85188604702en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage394en_US
dc.identifier.urihttps://doi.org/10.1093/ced/llad392
dc.identifier.urihttps://hdl.handle.net/11616/101894
dc.identifier.volume49en_US
dc.identifier.wosWOS:001167855400001en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofClinical and Experimental Dermatologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleComment on 'Immune response to COVID-19 mRNA vaccination in patients with psoriasis undergoing treatment with biologics'en_US
dc.typeEditorialen_US

Dosyalar